Boceprevir
Back to searchMolecule Structure
Scientific Name
Boceprevir
Description of the Drug
Boceprevir is a hepatitis C virus NS3/4A protease inhibitor used in combination with other medications to treat chronic hepatitis C genotype 1 infection. Boceprevir is not indicated as monotherapy.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB08873
http://www.drugbank.ca/drugs/DB08873
Brand Name(s)
Victrelis
Company Owner(s)
Merck Sharp And Dohme Corp
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Hepatitis C virus serine protease, NS3/NS4A | PROTEIN COMPLEX | INHIBITOR | CHEMBL2095231 |
